Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00334061 · ClinicalTrials.gov registry record · Phase 2
Study to Assess the Safety and Effectiveness of the Penumbra System
A Phase 2 study, sponsored by Penumbra.
- Completed
- Registry status
- Phase 2
- Development phase
- 125
- Enrollment target
NCT00334061 is a Phase 2 study that has completed, run by Penumbra. The registered enrollment target is 125 participants.
The verdict
NCT00334061, a Phase 2 study, has completed, sponsored by Penumbra.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 125 participants
- Enrollment target
Study Summary
This clinical evaluation is a prospective, single-arm, multi-center trial. The purpose of this clinical evaluation is to assess the safety and effectiveness of the Penumbra System in the revascularization of patients presenting with acute ischemic stroke secondary to intracranial, large vessel, occlusive disease.
Interventions
- DEVICE Penumbra System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2006-06 |
| Est. Completion | 2007-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00334061
The ClinicalTrials.gov registry entry for NCT00334061 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Penumbra, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Penumbra System is the first listed.
NCT00334061 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00334061 about?
NCT00334061 is a clinical study titled "Study to Assess the Safety and Effectiveness of the Penumbra System". This clinical evaluation is a prospective, single-arm, multi-center trial. The purpose of this clinical evaluation is to assess the safety and effectiveness of the Penumbra System in the revascularization of patients presenting with acute ischemic stroke secondary to intracranial, large vessel, occ...
What is the current status of trial NCT00334061?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 125 participants. The study started on 2006-06. Estimated completion is 2007-11.
What interventions are being tested in trial NCT00334061?
The interventions under investigation include: Penumbra System (DEVICE).
Who is sponsoring clinical trial NCT00334061?
This trial is sponsored by Penumbra, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.